Unlock regulatory insights with Watson. Learn More
Return to Docket

FDA Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing; Request for Comments

Type: Non-Rule Making
KeyWord(s) cder, nicotine, cder2012196, Smoking-Cessation , Congress, innovative products , tobacco, dependence, smoking prevention , Tobacco Control Act, non-nicotine, therapy
Docket Item Code N
Center CDER